Complement-Based Drug Development Summit leaderboard
  • Friday, September 4, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

17th World ADC San Diego Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Pharma Journalist
  • Page 551

Author

Pharma Journalist 9038 posts 0 comments

Pelican BioThermal announces Acquisition of NanoCool

Feb 7, 2020
Pelican BioThermal, the global name in temperature-controlled packaging, today announces the acquisition of NanoCool, an Albuquerque, New Mexico-based manufacturer of…
Read More...

Stevanato Group, Bormioli Pharma Partner on EZ-fill Packaging

Feb 7, 2020
Stevanato Group, through Ompi, its specialist in glass primary packaging for the pharmaceutical industry, and Bormioli Pharma announce today a collaboration agreement. The agreement…
Read More...

LSNE Expands Vial Filling And Lyophilization Capacity With Isolator Technology

Feb 7, 2020
LSNE Contract Manufacturing broke ground on a 26,000 square foot addition of its existing 7 Commerce facility on the Bedford, New Hampshire campus. This expansion further increases…
Read More...

ACG Inspection Introduces Groundbreaking Blockchain-based Brand Platform

Feb 7, 2020
ACG Inspection - one of the four businesses of ACG Group, the only supplier in the world offering end-to-end manufacturing solutions for the pharmaceutical industry - has introduced an…
Read More...

Assertio Therapeutics Announces Sale of NUCYNTA Franchise to Collegium Pharmaceutical for $375.0…

Feb 6, 2020
Assertio Therapeutics announced it has entered into a definitive agreement with Collegium Pharmaceutical, Inc. pursuant to which Collegium will acquire the NUCYNTA franchise of products…
Read More...

Aimmune Therapeutics Announces Additional $200 Million Equity Investment by Nestlé Health Science

Feb 6, 2020
Aimmune Therapeutics announced that Nestlé Health Science will make an additional equity investment in Aimmune of $200 million, bringing Nestlé’s total investment in Aimmune to date to…
Read More...

ReAlta Life Sciences Announces FDA Orphan Drug Designation for PIC1 for the Treatment of…

Feb 6, 2020
ReAlta Life Sciences announced that U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to PIC1-dPEG24 for the treatment of hypoxic-ischemic encephalopathy (HIE)…
Read More...

Stevanato Group signs an agreement with Pfeiffer Vacuum

Feb 5, 2020
Italian-based Stevanato Group, a leading producer of glass primary packaging and provider of integrated capabilities for combination products and the US-based Pfeiffer Vacuum…
Read More...

Immix Doses First Patient in USA in its Phase 1b/2a Trial in Patients with Advanced Solid Tumors

Feb 5, 2020
Immix Biopharma, Inc., announced that the first patient in the USA was dosed successfully in its flagship phase 1b/2a clinical trial testing Imx-110 in patients with refractory solid…
Read More...

Rebiotix, a Ferring Company, Completes Enrollment for First-Ever, Pivotal Phase 3 Clinical Trial of…

Feb 5, 2020
Rebiotix, a Ferring company, announced that it has completed enrollment of the pivotal Phase 3 clinical trial for RBX2660, an investigational therapy aimed at breaking the cycle of…
Read More...
Prev Next
Microbiome Movement USA Summit 2026
Cell Therapy for Autoimmune Disease Summit
Complement-Based Drug Development Summit
World CNS Summit South Korea
Novel CNS Biomarkers Summit Europe
8th CNS Drug Delivery Summit
Biomarker Operations & Biospecimen Management
2nd Obesity & Weight Loss Drug Development Summit Europe
RNA-Based Therapeutics & Vaccines Summit South Korea
RNA-Targeted Drug Discovery & Development Summit
mRNA Process Development & CMC Summit 2026
TPD & Induced Proximity Summit
Measuring Patient Engagement Summit Europe
Oligonucleotides Analytical Development & CMC Summit
11th CAR-TCR Summit
COPD Drug Development Summit
Neuropsychiatric Drug Development Summit
10th IPF Summit
ADC Payload Summit 2026
10th Antifibrotic Drug Development Summit 2026
Model-Informed Drug Development Summit 2026
IMPACCT Real-World Evidence Summit
Raw Materials for Cell & Gene Therapy Summit
10th Dermatology Drug Development Summit
9th Lab Asset & Facility Management Summit
TRP Supply Chain & Manufacturing Summit
Covalent Drug Discovery & Development Summit
7th Genome Editing Therapeutics Summit
16th World Clinical Biomarkers & Companion Diagnostics Summit
Lipid Nanoparticles Development Summit Europe
iPSC Drug Development Summit
17th World ADC San Diego
Oligonucleotides for CNS Summit
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • World ADC Awards 2026 Shortlist Announced, Recognizing Excellence Across the ADC Industry
  • Cipla Licenses HER2 Cancer Drug TQB2102 Across Emerging Markets
  • FDA Approves BESREMi for Essential Thrombocythemia After 30 Years
  • Teva Discusses Lower Medicaid Drug Prices With Trump Administration
  • Kazia Therapeutics Raises $40 Million to Advance Paxalisib Trials

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

World ADC Awards 2026 Shortlist Announced, Recognizing…

2nd T-Cell Engager for Autoimmune Disease Summit to Deliver…

2nd T-Cell Engager for Autoimmune Disease Summit Returns in…

New Era for Autoimmune T-Cell Engagers Takes Centre Stage…

From Innovation to Acquisition: CrossBridge Bio’s ADC…

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.